Phase II evaluation of metoprine in advanced pancreatic adenocarcinoma.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000188:drug therapy*; D011739:Pyrimethamine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000970:Antineoplastic Agents; C006308:metoprine; D011739:Pyrimethamine